🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

China Metastatic Liver Cancer Clinical Registry Cohort Database

Recruitingn/aAges 18 Years - 80 YearsAllAnhui Provincial Hospital
NCT07602504 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close collaboration with multiple participating centers nationwide. The primary objective is to establish a standardized, large-scale clinical cohort database specifically for metastatic liver cancer. By collecting comprehensive data on patient demographics, primary tumor characteristics, systemic therapies, and local interventions, this registry aims to elucidate the clinical patterns and prognostic factors of secondary liver malignancies. This database will serve as a robust platform for conducting high-quality real-world studies and advancing evidence-based clinical research in the management of metastatic liver cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients with histologically or radiologically confirmed metastatic liver cancer. 2. Age ≥ 18 years. 3. Patients who have voluntarily signed the informed consent form. 4. Patients with complete baseline clinical data. Exclusion Criteria: 1. Patients with primary liver cancer (e.g., hepatocellular carcinoma). 2. Patients with other malignant tumors that may interfere with the evaluation of liver metastasis. 3. Patients who have previously participated in other interventional clinical trials. 4. Patients with severe cognitive disorders or communication barriers that prevent informed consent. 5. Patients with incomplete or missing key clinical data.
💊

What it tests

  • Standard of Care for Metastatic Liver Cancer
📍

Where

3 sites
The First Affiliated Hospital of Bengbu Medical University
Bengbu, China
The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hefei, China
The Affiliated Hospital of Qingdao University
Qingdao, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy